| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | - | - | 0 | - | - | - | - |
| Total Income - EUR | 182 | 0 | - | - | - | 0 | - | - | - | - |
| Total Expenses - EUR | 15.863 | 5.852 | - | - | - | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | -15.681 | -5.852 | - | - | - | 0 | - | - | - | - |
| Net Profit/Loss - EUR | -15.681 | -5.852 | - | - | - | 0 | - | - | - | - |
| Employees | 1 | 0 | - | - | - | 0 | - | - | - | - |
Check the financial reports for the company - Andali Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.563 | 1.608 | - | - | - | 1.493 | - | - | - | - |
| Current Assets | 4.882 | 4.863 | - | - | - | 4.515 | - | - | - | - |
| Inventories | 1.505 | 1.489 | - | - | - | 1.383 | - | - | - | - |
| Receivables | 3.375 | 3.341 | - | - | - | 3.102 | - | - | - | - |
| Cash | 1 | 33 | - | - | - | 31 | - | - | - | - |
| Shareholders Funds | -43.215 | -48.625 | - | - | - | -45.144 | - | - | - | - |
| Social Capital | 45 | 45 | - | - | - | 41 | - | - | - | - |
| Debts | 52.660 | 55.097 | - | - | - | 51.153 | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Andali Pharma Srl